Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-007 + Bevacizumab in Metastatic Breast Cancer
NCT00394082Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Jun 2006
- Primary completion
- Sep 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Celgene Corporation. Started Jun 2006; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00394082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394082.